Efficacy and safety of autologous hematopoietic stem cell therapy for refractory Crohn's disease: A systematic review and meta-analysis

BACKGROUND: Autologous hematopoietic stem cell transplantation (HSCT) has been proposed for patients with refractory Crohn's disease (CD), but it is associated with mortality and adverse events; the balance between risks and benefits becomes significantly important in the therapy. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Xiao, Feng, Jue-Rong, Chen, Li-Ping, Liu, Shi, Zhang, Meng, Zhou, Zhou, Liu, Jing, Zhao, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500090/
https://www.ncbi.nlm.nih.gov/pubmed/28658168
http://dx.doi.org/10.1097/MD.0000000000007381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500090/
https://www.ncbi.nlm.nih.gov/pubmed/28658168
http://dx.doi.org/10.1097/MD.0000000000007381

Ejemplares similares